Roche

Conference Sponsors

Information

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients.

For more information, please visit roche.com.



Video
https://www.youtube.com/watch?v=4SXtbyDwAiY

Social media

Contact details

https://www.roche.com

Videos

Roche Industry Symposium: A clear picture in unresectable HCC: decisions & dynamics

Roche Industry Symposium: A clear picture in unresectable HCC: decisions & dynamics

Bruno Sangro · Clinica Universidad de Navarra
David Pinato · Imperial College London, England
Lorenza Rimassa · Humanitas University and IRCCS Humanitas Research Hospital

Documents & Links

One Liver Initiative - Millions of people are living with liver diseasewhich increases their risk of liver cancer. Find out how we’re addressing the challenges in diagnosing and treating liver disease to halt this progression.
International Liver Cancer Movement (ILCM)Roche is a proud member and supporter of the ILCM, a global incubator/connector facilitating community building & exchange in the field of liver cancer.
Roche`s HCC Expert seriesExplore a wealth of resources provided by a team of multidisciplinary experts sharing their clinical expertise on the HCC patient journey.
IMbrave251 clinical trial handoutPhase III, open-label, randomized study of atezo with lenva or sora versus lenva or sora alone in HCC previously treated with atezo + bev.
MORPHEUS HCC clinical trial handoutOpen-label randomized study evaluating efficacy & safety of multiple immunotherapy-based treatment combinations in patients with advanced liver cancers.

Log in